It's time once again for the Market Cap Game Show Holiday Edition, where intuition meets valuation and everyday life meets ...

Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, ...

Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as ...

In fraud and bot detection, people usually think of fingerprinting as the classic browser or device fingerprint. This comes ...

A sophisticated ClickFix campaign is targeting entities in the hospitality sector to infect them with the DCRat remote access ...

I pushed a key change to the Underscore music player over the weekend. Members can now click on any song in their collection ...

Rigel Pharmaceuticals has seen its fair value estimate nudged up from US$49.60 to US$51.20, with only a small adjustment to the discount rate from 7.12% to 7.14% and revenue growth assumptions kept at ...

Drs Harrington and Gibson’s annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ...

Putting a list into random order might seem like an unusual task, but it can be quite useful for many businesses. For example, you might want to randomly assign leads to salespeople, assign jobs to ...

Ocugen (OCGN) rated Buy as OCU410ST Stargardt trial advances; FDA/EMA alignment speeds path to approval. Read here for more ...